ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Cellectar Biosciences Inc

Cellectar Biosciences Inc (CLRB)

0,2589
0,015
( 6,15% )
Aktualisiert: 21:08:54

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
0,2589
Gebot
0,2569
Fragen
0,2588
Volumen
1.311.586
0,241 Tagesbereich 0,266
0,224 52-Wochen-Bereich 4,45
Marktkapitalisierung
Handelsende
0,2439
Handelsbeginn
0,2439
Letzte Trade
2762
@
0.2589
Letzter Handelszeitpunkt
21:08:53
Finanzvolumen
US$ 326.985
VWAP
0,249305
Durchschnittliches Volumen (3 Mio.)
2.697.798
Ausgegebene Aktien
41.269.830
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-
Erlöse
-
Nettogewinn
-37,98M

Über Cellectar Biosciences Inc

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs... Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and better safety as a result of fewer off-target effects. Its lead PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Cellectar Biosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CLRB. The last closing price for Cellectar Biosciences was US$0,24. Over the last year, Cellectar Biosciences shares have traded in a share price range of US$ 0,224 to US$ 4,45.

Cellectar Biosciences currently has 41.269.830 shares in issue. The market capitalisation of Cellectar Biosciences is US$10,07 million.

CLRB Neueste Nachrichten

Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare Conference

Oral Presentation Presented at ASH 2024 Showed Iopofosine I 131 Achieved an 83.6% ORR and Exceeded Primary and Secondary Efficacy Endpoints in Phase 2 CLOVER-WaM Study for Relapsed/Refractory...

Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate Restructuring

Evaluating strategic options for iopofosine I 131 a late-stage clinical program with compelling Phase 2 data and a substantial market opportunity Focusing on advancing radiotherapeutic assets...

Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update

Phase 2 CLOVER-WaM pivotal study data selected for oral presentation at 66th Annual American Society of Hematology Meeting and Exposition Raised approximately $19.4 million with potential to...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.01094.395161290320.2480.2660.23410565140.24662601CS
4-0.0482-15.69521328560.30710.36280.2297529429360.28500084CS
12-1.7211-86.92424242421.982.20.22426977980.42078842CS
26-2.1411-89.21252.42.550.22413582840.64310712CS
52-3.4811-93.0775401073.744.450.22411190761.71980053CS
156-0.2911-52.92727272730.556.75680.2245655971.98811891CS
260-2.3011-89.886718752.566.75680.2246915721.81877965CS

CLRB - Frequently Asked Questions (FAQ)

What is the current Cellectar Biosciences share price?
The current share price of Cellectar Biosciences is US$ 0,2589
How many Cellectar Biosciences shares are in issue?
Cellectar Biosciences has 41.269.830 shares in issue
What is the market cap of Cellectar Biosciences?
The market capitalisation of Cellectar Biosciences is USD 10,07M
What is the 1 year trading range for Cellectar Biosciences share price?
Cellectar Biosciences has traded in the range of US$ 0,224 to US$ 4,45 during the past year
What is the reporting currency for Cellectar Biosciences?
Cellectar Biosciences reports financial results in USD
What is the latest annual profit for Cellectar Biosciences?
The latest annual profit of Cellectar Biosciences is USD -37,98M
What is the registered address of Cellectar Biosciences?
The registered address for Cellectar Biosciences is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Cellectar Biosciences website address?
The website address for Cellectar Biosciences is www.cellectar.com
Which industry sector does Cellectar Biosciences operate in?
Cellectar Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
NVNINVNI Group Ltd
US$ 5,18
(247,65%)
344,82M
EVAXEvaxion Biotech AS
US$ 6,13
(68,41%)
52,98M
ELABPMGC Holdings Inc
US$ 3,0299
(53,03%)
72,88M
NEUPNeuphoria Therapeutics Inc
US$ 5,10
(46,13%)
24,31M
PCLAPicoCELA Inc
US$ 4,30
(39,61%)
3,61M
GODNUGolden Star Acquisition Corporation
US$ 3,60
(-72,01%)
13,32k
GODNGolden Star Acquisition Corporation
US$ 2,85
(-66,61%)
335,6k
NXTTNext Technology Holding Inc
US$ 1,40
(-53,95%)
2,19M
SGLYSingularity Future Technology Ltd
US$ 1,62
(-38,64%)
839,43k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90,11
(-38,07%)
8
ACONAclarion Inc
US$ 0,0567
(31,25%)
728,86M
NVNINVNI Group Ltd
US$ 5,18
(247,65%)
344,9M
GOEVCanoo Inc
US$ 0,4419
(33,91%)
266,47M
RIMEAlgorhythm Holdings Inc
US$ 0,0367
(7,62%)
252,1M
RGTIRigetti Computing Inc
US$ 13,325
(-1,08%)
195,06M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock